NPCE vs PG · rev $79.9M vs P/E 25, rev $84.28B
Neuropace Inc (NPCE) versus Procter & Gamble Company (PG) — a side-by-side from cached financials, not a winner call.
Neuropace Inc (NPCE) is a medical devices company listed on US.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Latest reported NPCE revenue for 2024-12-31 was $79.9M. Net income was -$27.1M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. NPCE currently screens at market cap $312.2M.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
NPCE currently screens at market cap $312.2M. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Not investment advice. Open the NPCE and PG stock pages for the full models.
Not investment advice.